Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Artists rendering of the Artemis I mission Orion space capsule with a cut away showing the two radiation detecting human phantoms. NASA/Lockheed Martin/DLR image

Google, NASA working to deploy AI medical assistant on space missions

A new natural language processing tool from Google is being trained on spaceflight scenarios to aid medical personnel on missions to the moon, Mars and beyond.

weight loss scale overweight obese lose weight pounds

Another win for Lilly: Oral GLP-1 drug linked to significant weight loss, other cardiovascular benefits

Tirzepatide and semaglutide are getting the attention now, but orforglipron could be the next go-to drug for patients hoping to lose weight and improve their heart health—no injections required.

Wildfire pollution image. Photo courtesy of the American Heart Association.

Air purifiers may reduce cardiovascular risks from pollution and wildfires

Multiple studies in recent years have linked poor air quality to significant cardiac risks. Air filters, however, have shown potential to help combat these risks.

pain pills opioids

Texas cardiologist to pay $1.2M for allegedly prescribing opioids to himself

The interventional cardiologist was accused of prescribing a variety of drugs to his family and friends, but then picking them up himself for his own personal use. This settlement officially resolves those allegations. 

Thumbnail

Too much screen time is bad for the heart

The excessive use of electronic devices is associated with significant health risks for young children and adolescents. In fact, too much screen time may impact the body in ways that last well into adulthood. 

Instylla Embrace Hydrogel Embolic System

New liquid embolic agent for hypervascular tumors gains FDA’s premarket approval

Instylla's Embrace Hydrogel Embolic System minimizes bleeding risks during the embolization of hypervascular tumors in the peripheral arteries.

merger acquisition M&A business

FTC challenges ‘anticompetitive’ TAVR acquisition

The FTC is working to stop Edwards Lifesciences from completing its acquisition of JenaValve. Edwards, however, is not backing down.

Reprocessed Supreme Fixed Electrophysiology Catheter

FDA announces new recall of reprocessed EP catheters due to risk of contamination

Customers with these devices on hand are asked to return them right away. No serious injuries have been reported at this time, but the presence of residual particulates can lead to such side effects as pulmonary embolism and deep vein thrombosis.